drugset

drugset / Trial / NCT00040638

Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

NCT00040638 ↗

Phase 2 Completed 40 enrolled Telik

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effectiveness of TLK286 in the treatment of advanced non-small cell lung cancer.

Timeline

Start: 2002-07
Primary completion: 2003-08
Completion: 2003-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	canfosfamide	Small molecule	—	—

Indications